Faculty

Institution

Unit

Venue

Kast, Wijbe M., PhD

PhD

University of Southern California

Affiliations

Keck School of Medicine

Molecular Microbiology and Immunology

Otolaryngology

Kast, Wijbe M., Phd is currently serving as a Keck School Of Medicine PhD at University of Southern California.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kast, Wijbe M., PhD

University of Southern California

PhD

You can click a keyword to filter the displayed items

immunology oncology medicine cancer immunotherapy cancer research health sciences immune responses virology medicinal research cancer biology immunotherapy dermatology clinical immunology vaccination cancer treatment viral oncology cancer care adaptive immune system vaccines general virology virus research cellular therapy medical virology vaccine research tumor targeting vaccine development cancer immunosurveillance virus-host interactions dendritic cells gynecologic oncology experimental medicine hla typing mammalian biology viral pathogenesis cancer prevention clinical microbiology cellular immune responses infection control viral genetics cytokines histocompatibility cancer genomics host factors langerhans cells cancer cells leukemia cell regulation molecular immunology immunomodulation human papillomavirus oncogenes respiratory medicine clinical evidence t-regulatory cell lymphoid neoplasia cancer management cancer risk treatment and prevention therapeutic vaccines peptides vaccine efficacy host specificity melanoma peptide vaccination cervical carcinoma dna vaccine human dendritic cells rma-s cells cervical cancer vaccines immune cells primary tumors peptide-based vaccines murine model therapeutic vaccination cancer patients human ovarian cancer

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 6536: Enhanced Membrane Stability of Mrna Nanoparticle Derived Tnfsf14 Results in Superior T-Cell and Nk Cell Stimulation. Cancer research (2024)

Adrienne SalletsWeiqun LiuMeredith L. LeongRuben PrinsDiane M. Da SilvaDaniel J. FernandezColin J. McKinlayEdward E. LemmensChris S. RaeSudha AdusumilliRay LowSrinivasa BandiGuna KannanW. Martin KastSamuel DeutschOle A. Haabeth

mrna nanoparticleimmunologytumor biologycancer researchnanoparticle researchcancer treatmentradiation oncologynanomedicinemedicinal researchmolecular cancercancer caremembrane stabilitycancer biologytumor targetingbiomedical engineeringnk cell stimulationclinical researchcancer genomicsoncology

Germline Genetic Regulation of the Colorectal Tumor Immune Microenvironment. BMC Genomics (2024)

Stephanie L. SchmitYa-Yu TsaiJoseph D. BonnerRebeca Sanz-PamplonaAmit D. JoshiTomotaka UgaiSidney S. LindseyMarilena MelasKevin J. McDonnellGregory E. IdosChristopher P. WalkerChenxu QuW. Martin KastDiane M. Da SilvaJonathan N. GlickmanAndrew T. ChanMarios GiannakisJonathan A. NowakHedy S. RennertHarlan S. RobinsShuji OginoJoel K. GreensonVictor MorenoGad RennertStephen B. Gruber

colorectal cancercancer biologyimmunologygermline genetic regulationgenomicsmolecular biologytumor microenvironmentcancer geneticsoncologygenetics

Medical and Cancer-Stem Education in Audiology, Gastroenterology, and Osteology/Orthopedics for Underrepresented Elementary School Students. Connected science learning (2024)

Katlyne StilesSurbhi BansilBrittany AcevedoW. Martin KastDieuwertje J. Kast

cancer-stem educationgastroenterologymedical educationaudiologymedicine

134 Mntx-250, a Novel Multimodal Hpv-16 Mrna-Based Therapeutic, Induces Potent Anti-Tumor Responses and Establishes Hpv-16 Specific Immune Memory. Regular and Young Investigator Award Abstracts (2023)

Ou LiNicole FayDiane Da SilvaRuben PrinDaniel FernandezStephanie WongZhang-Xu LiuMartin KastRob Schott

tumor biologyviral geneticscancer immunotherapyvaccine developmentimmunologymedicinal researchviral oncologyimmunotherapymolecular cancercellular therapyimmunomodulationimmune responsesmedicinetherapeutic targetscytokinesgeneral virologygeneticsvirus research

Data From Nanobody–Antigen Conjugates Elicit Hpv-Specific Antitumor Immune Responses. (2023)

Andrew W. WoodhamRoss W. ChelohaJingjing LingMohammad RashidianStephen C. KolifrathMaia MesyngierJoao N. DuarteJustin M. BaderJoseph G. SkeateDiane M. Da SilvaW. Martin KastHidde L. Ploegh

nanobody-antigen conjugatescancer immunotherapyimmunologyimmune responsesadaptive immune system

Diversity of Anal Hpv and Non-Hpv Sexually Transmitted Infections and Concordance With Genital Infections in Hiv-Infected and Hiv-Uninfected Women in the TapajóS Region, Amazon, Brazil. Viruses (2023)

Luana Lorena Silva RodriguesJosé Henrique PilottoKatrini Guidolini MartinelliAlcina F. NicolVanessa Salete De PaulaTarik GheitNathália Silva Carlos OliveiraCarlos Silva-de-JesusVikrant V. SahasrabuddheDiane M. Da SilvaW. Martin KastJustin HardickCharlotte A. GaydosMariza Gonçalves Morgado

genital infectionstapajos regionepidemiologyvirus epidemiologyinfectious diseasesvirologyhiv-uninfected womenhivrespiratory medicineglobal healthvirus transmissionsexual health

Figure S1 From Immune Activation in Patients With Locally Advanced Cervical Cancer Treated With Ipilimumab Following Definitive Chemoradiation (Gog-9929). (2023)

Diane M. Da SilvaDanielle M. EnserroJyoti S. MayadevJoseph G. SkeateKoji MatsuoHuyen Q. PhamHeather A. LankesKatherine M. MoxleySharad A. GhamandeYvonne G. LinRussell J. SchilderMichael J. BirrerW. Martin Kast

gynecologic oncologyradiation oncologyanti-cancer agentscancer immunotherapyimmunologyimmune activationimmunotherapydefinitive chemoradiationcancer researchcervical canceradvanced cervical cancercancer treatmentcancer careoncologycytokines

Heterozygote Advantage at Hla Class I and II Loci and Reduced Risk of Colorectal Cancer. Frontiers in immunology (2023)

Ya-Yu TsaiChenxu QuJoseph D. BonnerRebeca Sanz-PamplonaSidney S. LindseyMarilena MelasKevin J. McDonnellGregory E. IdosChristopher P. WalkerKevin K. TsangDiane M. Da SilvaFerran Moratalla-NavarroAsaf MaozHedy S. RennertW. Martin KastJoel K. GreensonVictor MorenoGad RennertStephen B. GruberStephanie L. Schmit

colorectal cancerimmunologyhematologyhla typingcancer riskheterozygote advantagereduced riskgenetics

Supplementary Data From Vaccination Against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. (2023)

Greta GarridoBrett SchrandAgata LevayAilem RabasaAnthony FerrantellaDiane M. Da SilvaFrancesca D'EramoKoen A. MarijtZhuoran ZhangDeukwoo KwonMarcin KortylewskiW. Martin KastVikas DudejaThorbald van HallEli Gilboa

public healthfuture tumorssupplementary datavaccinationimmunologycancer researchmedicineoncologycancer biology

1084 Ntx-0250, a Multimodal Mrna-Based Immunotherapy, Eradicates Large Established Tumors in a Stringent Mouse Model of Hpv16-Driven Cancer. Regular and Young Investigator Award Abstracts (2022)

Ole HaabethDiane DaSilvaColin McKinlayWeiqun LiuEdward LemmensChristopher RaeAdrienne SalletsDaniel FrimannssonSangeeta NathNicole PeckOu LiNicole FayRuben PrinsMeredith LeongW Martin KastSamuel Deutsch

anti-cancer agentspharmacologytumor biologycancer immunotherapyimmunotherapycancer researchtumor suppressorsmolecular biologycancer treatmentstringent mouse modelradiation oncologymedicinal researchclinical investigationmolecular cancerviral oncologycancer careexperimental medicinemultimodal mrna-based immunotherapycancer genomicsoncology

1
2
3
4
5
21
10 / page

Kast, Wijbe M., PhD

PhD

University of Southern California

Affiliations

Keck School of Medicine

Molecular Microbiology and Immunology

Otolaryngology

Kast, Wijbe M., Phd is currently serving as a Keck School Of Medicine PhD at University of Southern California.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kast, Wijbe M., PhD

University of Southern California

PhD

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 6536: Enhanced Membrane Stability of Mrna Nanoparticle Derived Tnfsf14 Results in Superior T-Cell and Nk Cell Stimulation. Cancer research (2024)

Germline Genetic Regulation of the Colorectal Tumor Immune Microenvironment. BMC Genomics (2024)

colorectal cancercancer biologyimmunologygermline genetic regulationgenomicsmolecular biologytumor microenvironmentcancer geneticsoncologygenetics

Medical and Cancer-Stem Education in Audiology, Gastroenterology, and Osteology/Orthopedics for Underrepresented Elementary School Students. Connected science learning (2024)

Katlyne StilesSurbhi BansilBrittany AcevedoW. Martin KastDieuwertje J. Kast

cancer-stem educationgastroenterologymedical educationaudiologymedicine

Ou LiNicole FayDiane Da SilvaRuben PrinDaniel FernandezStephanie WongZhang-Xu LiuMartin KastRob Schott

Data From Nanobody–Antigen Conjugates Elicit Hpv-Specific Antitumor Immune Responses. (2023)

Andrew W. WoodhamRoss W. ChelohaJingjing LingMohammad RashidianStephen C. KolifrathMaia MesyngierJoao N. DuarteJustin M. BaderJoseph G. SkeateDiane M. Da SilvaW. Martin KastHidde L. Ploegh

nanobody-antigen conjugatescancer immunotherapyimmunologyimmune responsesadaptive immune system

genital infectionstapajos regionepidemiologyvirus epidemiologyinfectious diseasesvirologyhiv-uninfected womenhivrespiratory medicineglobal healthvirus transmissionsexual health

Figure S1 From Immune Activation in Patients With Locally Advanced Cervical Cancer Treated With Ipilimumab Following Definitive Chemoradiation (Gog-9929). (2023)

Heterozygote Advantage at Hla Class I and II Loci and Reduced Risk of Colorectal Cancer. Frontiers in immunology (2023)

colorectal cancerimmunologyhematologyhla typingcancer riskheterozygote advantagereduced riskgenetics

Supplementary Data From Vaccination Against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. (2023)

public healthfuture tumorssupplementary datavaccinationimmunologycancer researchmedicineoncologycancer biology

1084 Ntx-0250, a Multimodal Mrna-Based Immunotherapy, Eradicates Large Established Tumors in a Stringent Mouse Model of Hpv16-Driven Cancer. Regular and Young Investigator Award Abstracts (2022)

1
2
3
4
5
21
10 / page

Similar Faculty Members

Otoniel Martinez-Maza

Institution

University of California, Los Angeles

viral oncology

immune dysfunction

Eli Gilboa

Institution

University of Miami

cellular therapy

immune response

Bellur S Prabhakar

Institution

University of Illinois Chicago

cellular therapy

immune response

Olivera J. Finn

Institution

University of Pittsburgh

cancer letter

immunotherapy

Zihai Li

Institution

Ohio State University

biomedical informatics

systems biology

Herbert Kim Lyerly

Institution

Duke University

immunology

oncology

Jenny Ting

Institution

University of North Carolina at Chapel Hill

gene discovery

innate immune system

Edgar Engleman

Institution

Stanford University

cellular therapy

immune response

Walter J. Storkus

Institution

University of Pittsburgh

immunomodulation

tumor immunobiology

Alex K. Shalek

Institution

Massachusetts Institute of Technology

molecular features

immunology

Similar Faculty Members

Otoniel Martinez-Maza

Institution

University of California, Los Angeles

viral oncology

immune dysfunction

Eli Gilboa

Institution

University of Miami

cellular therapy

immune response

Bellur S Prabhakar

Institution

University of Illinois Chicago

cellular therapy

immune response

Olivera J. Finn

Institution

University of Pittsburgh

cancer letter

immunotherapy

Zihai Li

Institution

Ohio State University

biomedical informatics

systems biology

Herbert Kim Lyerly

Institution

Duke University

immunology

oncology

Jenny Ting

Institution

University of North Carolina at Chapel Hill

gene discovery

innate immune system

Edgar Engleman

Institution

Stanford University

cellular therapy

immune response

Walter J. Storkus

Institution

University of Pittsburgh

immunomodulation

tumor immunobiology

Alex K. Shalek

Institution

Massachusetts Institute of Technology

molecular features

immunology